1861579849

1861579849 was paid $6.32M by Medicaid between Jan 2018 and Dec 2024, across 108 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.

33Billing provider info1861579849

33aNPI1861579849

33bProvider type—

28Total paid$6.32M

24GClaims242,249

24DCodes billed108

24AFirst – last monthJan 2018 – Dec 2024

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	6,956	$89K
2019	48,608	$545K
2020	34,419	$423K
2021	44,739	$1.04M
2022	46,974	$1.50M
2023	39,562	$1.64M
2024incomplete	20,991	$1.09M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	42%	26,335	23,889	$2.68M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	14%	17,569	14,861	$904K
80053	Comprehensive metabolic panel	6.9%	16,014	12,773	$434K
74177	Computed tomography, abdomen and pelvis; with contrast material	6.7%	2,273	1,961	$425K
99282	Emergency department visit for the evaluation and management, low to moderate severity	6.5%	3,725	3,516	$409K
70450	Computed tomography, head or brain; without contrast material	4.0%	2,340	1,944	$254K
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.8%	1,170	1,079	$117K
87070		1.8%	3,959	3,736	$111K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	1.7%	2,435	1,931	$108K
74176	Computed tomography, abdomen and pelvis; without contrast material	1.5%	640	562	$96K
87400		1.1%	7,711	7,175	$73K
71275	Computed tomographic angiography, chest, with contrast material	<1%	111	103	$51K

96 more codes

87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	6,621	$41K
81025		<1%	6,532	$39K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,478	$36K
72125	Computed tomography, cervical spine; without contrast material	<1%	408	$34K
80048	Basic metabolic panel (calcium, ionized)	<1%	2,273	$33K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	3,561	$32K
A9270	Non-covered item or service	<1%	6,663	$30K
87040		<1%	1,823	$22K
84484		<1%	5,393	$22K
J7030	Infusion, normal saline solution , 1000 cc	<1%	7,009	$21K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	732	$21K
81001		<1%	6,716	$20K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	5,905	$20K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	4,187	$20K
71045	Radiologic examination, chest; single view	<1%	4,908	$19K
J3490	Unclassified drugs	<1%	939	$17K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	293	$17K
85027		<1%	18,393	$16K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	9,872	$16K
71046	Radiologic examination, chest; 2 views	<1%	1,814	$14K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,529	$13K
76830	Ultrasound, transvaginal	<1%	114	$12K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,700	$11K
G0378	Hospital observation service, per hour	<1%	1,856	$11K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	3,884	$11K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	4,859	$8K
87086	Culture, bacterial; quantitative colony count, urine	<1%	600	$7K
81003		<1%	3,484	$7K
85610		<1%	3,549	$6K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,078	$4K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	187	$4K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	69	$4K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	1,006	$4K
87210		<1%	669	$4K
73630		<1%	285	$4K
87081		<1%	22	$4K
83605		<1%	1,500	$3K
72131		<1%	33	$3K
83690		<1%	4,326	$3K
85730		<1%	2,922	$3K
73130		<1%	109	$3K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	2,602	$3K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	219	$3K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,270	$2K
84703		<1%	1,280	$2K
73564		<1%	162	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	375	$2K
J2704	Injection, propofol, 10 mg	<1%	169	$2K
S0028	Injection, famotidine, 20 mg	<1%	475	$1K
73110		<1%	45	$1K
85379		<1%	861	$1K
84702		<1%	549	$1K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	49	$1K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,085	$1K
96375	Therapeutic injection; each additional sequential IV push	<1%	3,614	$971.11
83735		<1%	2,210	$864.92
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,035	$795.28
73030		<1%	50	$756.21
76376		<1%	125	$735.67
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	204	$668.24
73610		<1%	123	$661.71
87420		<1%	1,013	$649.08
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	189	$611.36
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	84	$547.76
82150		<1%	1,593	$457.58
86900		<1%	674	$399.53
83880		<1%	824	$376.42
84443	Thyroid stimulating hormone (TSH)	<1%	573	$330.96
J7050	Infusion, normal saline solution, 250 cc	<1%	284	$222.86
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,239	$164.37
96376		<1%	727	$73.30
83036	Hemoglobin; glycosylated (A1C)	<1%	32	$62.25
87186		<1%	151	$56.36
80061	Lipid panel	<1%	90	$42.58
90714		<1%	28	$31.76
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	140	$31.06
82550		<1%	109	$6.00
86901		<1%	661	$4.40
84100		<1%	69	$1.66
J1170	Injection, hydromorphone, up to 4 mg	<1%	138	$0.61
88305	Level IV - Surgical pathology, gross and microscopic examination	0%	84	$0.00
85652		0%	12	$0.00
87205		0%	96	$0.00
J2060	Injection, lorazepam, 2 mg	0%	548	$0.00
J1815	Injection, insulin, per 5 units	0%	163	$0.00
86850		0%	305	$0.00
96361	Intravenous infusion, hydration; each additional hour	0%	16	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	19	$0.00
G1003	Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program	0%	77	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	77	$0.00
81002		0%	32	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	16	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	33	$0.00
90715		0%	15	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	37	$0.00
97163		0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.